Why is Biocon falling/rising?

As of 04-Aug, Biocon Ltd. is currently priced at 382.45, reflecting a decrease of 0.65, or 0.17%. The stock has been underperforming, having fallen for the last four consecutive days, resulting in a total decline of 4.02% during this period. In terms of returns, Biocon has shown a 1-week decline of 1.28%, while it has performed better over the longer term with a 1-month increase of 0.61% and a year-to-date rise of 4.91%. Despite these positive longer-term trends, the stock's recent performance has been hindered by a drop in investor participation, as evidenced by a 19.11% decrease in delivery volume compared to the 5-day average. Additionally, while the stock is trading at a discount compared to its peers, its profits have decreased by 7.3% over the past year, which may be contributing to the current downward pressure.
In the broader market context, the Sensex has shown a slight increase of 0.16% over the past week, contrasting with Biocon's decline. This indicates that the stock is not only underperforming relative to the market but also to its sector, as it has underperformed by 0.55% today. The high institutional holdings at 28.86% suggest that knowledgeable investors are still confident in the company's fundamentals, as their stake has increased by 7.47% over the previous quarter. However, the combination of falling investor participation and recent profit declines may be overshadowing these positive indicators, leading to the stock's current downward trend.